Equity ETFs M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound By Max ChenSeptember 12, 2016
Equity ETFs Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs By Max ChenMay 16, 2016
Equity ETFs Health Care ETFs Can Still Strengthen on Increased M&A Activity By Max ChenApril 28, 2016
Equity ETFs Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal By Max ChenApril 6, 2016
Contributed ETF Chart of the Day: Biotechnology Breakthroughs By Paul Weisbruch, Street One FinancialJuly 31, 2015